Stockreport

SAB BIO Reports Full Year 2024 Operating and Financial Results

SAB Biotherapeutics, Inc.  (SABS) 
PDF MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy p [Read more]